Peptides studied in glucose-handling and insulin-signaling research models.
Research Articles
Retatrutide Verification Checklist 2026
10-point research-grade retatrutide verification checklist — third-party HPLC, MS identity, COA review, and red-flag detection after the 2025–2026 quality crisis.
Read article →ArticleGLP-1 Receptor Agonism Explained: Molecular Mechanism Deep Dive
Deep dive on GLP-1 receptor agonism — binding affinities, signaling cascades, GIP/GLP-1 dual agonism, and triple-agonist research from 2024–2026 literature.
Read article →ArticleTirzepatide vs Retatrutide: Mechanism & Efficacy 2026
Side-by-side comparison of tirzepatide (GLP-1/GIP dual) and retatrutide (GLP-1/GIP/glucagon triple) — efficacy, mechanism, safety, and research selection criteria.
Read article →ArticleTRIUMPH-4 Retatrutide Trial Design 2026
TRIUMPH-4 retatrutide Phase 3 trial design — Phase 3 outcomes pending; Phase 2 data (PMID 37366315) shows up to 24.2% mean weight reduction at…
Read article →